Form 4: Bausch Health CEO Earns 1.1M Performance Shares

Bausch Health CEO Thomas Appio earned over 1.1 million common shares after meeting performance targets for the 2023-2025 period.

Summary

• Thomas Appio, Chief Executive Officer and Director of Bausch Health Companies Inc. (BHC), acquired 1,137,862 common shares.
• The acquisition occurred on February 9, 2026, and represents performance-based restricted share units (PSUs) originally granted on March 2, 2023.
• These PSUs were earned upon certification by the Talent and Compensation Committee of the Board of Directors that financial performance metrics for the period from January 1, 2023, through December 31, 2025, were achieved.
• The earned PSUs remain subject to a service-based vesting condition through March 2, 2026.
• Following this transaction, Thomas Appio beneficially owns 2,921,111 common shares.
• The shares were acquired at a price of $0, as they represent the earning of previously granted PSUs.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong positive signal, as the CEO's earning of performance-based shares indicates successful achievement of financial targets, which typically reflects well on the company's operational and strategic execution.

Positives

• The earning of performance-based restricted share units by the CEO indicates that Bausch Health Companies Inc. successfully met its financial performance metrics for the 2023-2025 period.
• This transaction aligns the interests of the CEO with those of shareholders, as his compensation is directly tied to company performance.

Future Outlook

The earned performance-based restricted share units are still subject to a service-based vesting condition through March 2, 2026. Upon satisfaction of this condition, the company will deliver the common shares to the CEO as soon as administratively practicable.

Industry Context

StockSavvy.ai notes that executive compensation tied to performance metrics, such as the PSUs earned by Bausch Health's CEO, is a common practice across the pharmaceutical and healthcare industries. This structure aims to incentivize leadership to achieve strategic and financial goals, thereby aligning their interests with long-term shareholder value creation. The successful earning of these shares suggests positive internal performance against pre-defined targets, which can be a leading indicator for the company's operational health within its competitive landscape.

Corporate Governance

Stakeholder Impact

• Shareholders: Positive impact as the CEO's compensation is directly linked to the achievement of financial performance metrics, aligning management incentives with shareholder value.
• Employees: May signal a positive outlook for the company's performance, potentially boosting morale and confidence.

Next Steps

• Satisfaction of the service-based vesting condition by the Reporting Person through March 2, 2026.
• Delivery of the earned common shares to the Reporting Person by the Issuer as soon as administratively practicable after the service-based vesting condition is met.

Key Dates

Recommendation

The earning of a substantial number of performance-based shares by the CEO signals strong internal performance against financial targets. This insider acquisition, even if through compensation, indicates management confidence and successful execution, which is a positive indicator for investors. It suggests the company is meeting its strategic objectives, making it an attractive 'buy' signal for a seasoned investor.

Keywords

Bausch Health, BHC, Thomas Appio, CEO, Performance Shares, Restricted Share Units, Executive Compensation, Insider Transaction, SEC Form 4